tradingkey.logo
tradingkey.logo
Search

GeneDx Holdings Corp

WGSWW
Add to Watchlist
0.004USD
-0.000-5.26%
Close 07/02, 13:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

More Details of GeneDx Holdings Corp Company

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

GeneDx Holdings Corp Info

Ticker SymbolWGSWW
Company nameGeneDx Holdings Corp
IPO dateSep 04, 2020
CEOMs. Katherine A. Stueland
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address333 Ludlow Street
CitySTAMFORD
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code06902
Phone18887291206
Websitehttps://sema4.com/
Ticker SymbolWGSWW
IPO dateSep 04, 2020
CEOMs. Katherine A. Stueland

Company Executives of GeneDx Holdings Corp

Name
Name/Position
Position
Shareholding
Change
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
--
--
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
--
--
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of GeneDx Holdings Corp?

The top five shareholders of GeneDx Holdings Corp are: Dr. Thomas Fuchs